Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Form Health vs Virta Health

Form Health
Graded #323

Higher grade

vs+0.6999999999999957
Virta Health
Graded #337

Lower grade

The verdict

Form Health takes it — 60.4/100 to 59.7/100, but only just.

Form Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight. Virta Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVirta Health +17
28
45
Dose & formulationForm Health +26
77
51
Clinical oversightForm Health +9
86
77
Labs & monitoringVirta Health +19
52
71
FulfillmentForm Health +16
81
65
Contract termsVirta Health +14
41
55
Form Health · left barVirta Health · right bar

The numbers

MetricForm HealthVirta Health
WeighScore60.4/10059.7/100
GradeCC
Scorecard rank#323#337
Semaglutide$1,350/mo (starting dose, brand-name)Not disclosed
Tirzepatide$1,350/mo (starting dose, brand-name)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Form Health

Graded #323 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

Where it loses points

  • Higher brand-name pricing only
  • Premium pricing relative to market
Virta Health

Graded #337 · C

Strengths

  • Offers a Responsible Prescribing track with optimized GLP-1 use
  • Clinically monitored medication off-ramp toward nutrition therapy
  • Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
  • Provided at no cost to members through employers and health plans
  • Strong evidence base for diabetes reversal and metabolic health

Where it loses points

  • Primarily a nutrition program; GLP-1s are a secondary track
  • Distributed via employers and health plans, no direct cash-pay
  • Deliberately discourages GLP-1 use for most members
  • GLP-1 access depends on the specific program the plan selects

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard